PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s)
40102033,Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy.,2025,Mengyao Ma; Ximu Li; Mingyuan Zhong; Xuejing Li; Jiang Yu; Qingzhi Lv; Zhonggui He; Hongzhuo Liu; Yongjun Wang,"Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; School of Pharmacy, Binzhou Medical University, Yantai 264003, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China."
